Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.

ABSTRACT:

SUBMITTER: Ye L 

PROVIDER: S-EPMC8899907 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature